The latest addition to MRC Holland’s digitalMLPA portfolio, NXtec™ D038 Carrier Plus, is a comprehensive high-throughput assay for carrier status determination.
When it comes to CNVs in highly homologous and complex genomic regions, routine sequencing approaches do not always provide the complete picture. Designed specifically for this challenge, NXtec Carrier Panels combine the specificity of MLPA with the throughput of NGS, enabling reliable carrier status determination for a broad range of inherited conditions.
Building on the foundation of the NXtec D028 Carrier Panel 1– which targets challenging regions such as SMN1, DMD, CYP21A2, HBA and HBB – NXtec D038 Carrier Plus expands coverage to genes associated with 26 autosomal recessive and X-linked disorders, including fragile X syndrome, Gaucher disease, Tay-Sachs disease, Bloom syndrome, galactosemia, phenylketonuria, and hemophilia A.
* Costs based on digitalMLPA reagent list prices; possible additional costs not included. Prices may differ when ordering through our sales partners.
To celebrate the launch of NXtec D038 Carrier Plus, we are offering a 40% discount to first-time digitalMLPA users, valid until 30th of April 2027. Contact us to receive your personal quote.
Are you an existing digitalMLPA user? Then also contact us for an attractive discount!
Below there is a comparison between D028 Carrier Panel 1 and D038 Carrier Plus. For more detailed information, visit D028 and D038 product pages.

For Research Use Only. Not for Use in Diagnostic Procedures.